(EVT) Evotec SE - Performance -20.6% in 12m
Compare EVT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-69.35%
#128 in Group
Rel. Strength
24.50%
#6008 in Universe
Total Return 12m
-20.64%
#102 in Group
Total Return 5y
-66.21%
#107 in Group
P/E -
(?) Percentile in Group
P/E Forward 61.4
84th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -7.52%
24th Percentile in Group
12m Total Return: EVT (-20.6%) vs XLV (-5.9%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-3.75% | 164% | 412% | 58.1 | 44.4 | 0.61 | 48.6% | 9.63% |
LLY NYSE Eli Lilly |
-2.54% | -4.17% | 393% | 67 | 36.6 | 1.33 | 58.2% | 18.9% |
NVS NYSE Novartis |
4.67% | 12.4% | 62.5% | 17.9 | 13.9 | 1.36 | 8.40% | 9.2% |
NOVN SW Novartis |
9.58% | 1.99% | 40% | 19.3 | 13.9 | 1.32 | 9.80% | 11.2% |
SOBI ST Swedish Orphan Biovitrum |
21.6% | 4.1% | 49.3% | 25.6 | 20.9 | 1.61 | 16.1% | 29% |
SAN PA Sanofi |
7.1% | 3.86% | 21.9% | 19.2 | 11.7 | 0.88 | -16.5% | 12.2% |
IPN PA Ipsen |
9.35% | -14.1% | 58.7% | 23.3 | 9.65 | 0.69 | -6.40% | -6.33% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.19% | 5.67% | 36% | 24.6 | 20.2 | 1.47 | -5.90% | -17% |
Performance Comparison: EVT vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for EVT
Total Return (including Dividends) | EVT | XLV | S&P 500 |
---|---|---|---|
1 Month | 43.87% | -4.38% | 2.87% |
3 Months | -11.82% | -8.96% | -6.42% |
12 Months | -20.64% | -5.92% | 9.87% |
5 Years | -66.21% | 41.93% | 107.51% |
Trend Score (consistency of price movement) | EVT | XLV | S&P 500 |
1 Month | 80.0% | -9.7% | 89.4% |
3 Months | -48.6% | -77% | -72% |
12 Months | -30.5% | -30.6% | 49.3% |
5 Years | -83.4% | 89.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #16 | 50.5% | 39.9% |
3 Month | #99 | -3.14% | -5.77% |
12 Month | #102 | -15.7% | -27.8% |
5 Years | #110 | -76.2% | -83.7% |
FAQs
Does EVT Evotec SE outperforms the market?
No,
over the last 12 months EVT made -20.64%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.92%.
Over the last 3 months EVT made -11.82%, while XLV made -8.96%.
Over the last 3 months EVT made -11.82%, while XLV made -8.96%.
Performance Comparison EVT vs Indeces and Sectors
EVT vs. Indices EVT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.90% | 41.0% | -8.99% | -30.5% |
US NASDAQ 100 | QQQ | 0.65% | 39.2% | -9.40% | -32.0% |
US Dow Jones Industrial 30 | DIA | 0.62% | 42.3% | -7.96% | -27.0% |
German DAX 40 | DAX | -1.22% | 24.6% | -34.6% | -45.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.24% | 37.6% | -8.22% | -26.3% |
Hongkong Hang Seng | HSI | -2.62% | 27.7% | -18.5% | -32.7% |
India NIFTY 50 | INDA | 3.29% | 41.6% | -10.9% | -23.0% |
Brasil Bovespa | EWZ | -1.15% | 32.3% | -18.2% | -14.2% |
EVT vs. Sectors EVT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.72% | 40.2% | -15.2% | -41.0% |
Consumer Discretionary | XLY | -0.02% | 40.4% | -6.80% | -34.7% |
Consumer Staples | XLP | 1.27% | 41.9% | -15.9% | -28.2% |
Energy | XLE | -0.08% | 43.8% | -2.99% | -10.9% |
Financial | XLF | 0.27% | 38.3% | -14.9% | -42.2% |
Health Care | XLV | 4.69% | 48.3% | -3.76% | -14.7% |
Industrial | XLI | -0.67% | 36.5% | -9.97% | -30.6% |
Materials | XLB | 0.91% | 39.2% | -4.94% | -14.6% |
Real Estate | XLRE | 1.23% | 37.8% | -11.4% | -34.1% |
Technology | XLK | 0.01% | 37.1% | -6.72% | -27.6% |
Utilities | XLU | -0.14% | 38.3% | -16.8% | -36.6% |
Aerospace & Defense | XAR | 0.39% | 34.5% | -18.3% | -45.8% |
Biotech | XBI | 8.98% | 41.9% | 12.1% | -6.62% |
Homebuilder | XHB | 1.34% | 40.8% | 4.64% | -10.9% |
Retail | XRT | 0.75% | 40.3% | -2.70% | -16.3% |